EBMT-EHA CAR-T 2019 | CAR T-cell therapy going forward

Max Topp

Max Topp, MD, from the University of Würzburg, Würzburg, Germany, discusses immunotherapy for hematlogical malignancies and his highlights from the 1st European CAR T-Cell Meeting, held in Paris, France, co-organized by the European Society for Blood & Marrow Transplantation (EBMT) and the European Hematology Association (EHA).

Share this video  
Similar topics